BRIGHT MINDS BIOSCIENCES INC. Adjustments For Unrealised Foreign Exchange Losses Gains
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -CAD 10.13 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2024-12-31
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 4 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|
| 2024-09-30 | -10.13K CAD 20-F · filed 2024-12-31 | |
| 2023-09-30 | 45.35K CAD 20-F · filed 2024-12-31 | |
| 2022-09-30 | -258.82K CAD 20-F · filed 2024-12-31 | |
| 2021-09-30 | -223.79K CAD 20-F · filed 2023-12-29 | |
| 2020-09-30 | 0.00 CAD 20-F · filed 2022-12-29 | |
| 2019-09-30 | 0.00 CAD 20-F/A · filed 2022-01-18 |